TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/25/2024
Back to search
Official data from USPTO
PARADIGM CLINICAL RESEARCH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PARADIGM CLINICAL RESEARCH
ST13
US500000097817996Class
35, 42
Filing
97817996
Registration
7436893
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
07/25/2024
Trademark type
Word
Nice classes
35, 42
Filing date
03/01/2023
Registration date
07/09/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/09/2024
Last transaction
07/25/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
2022-06-00
First use in commerce
2022-06-00
Drawing code
4
Owner type
16
Owner location
Boise, ID, US
Examiner
BARREDA, AMBER
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Paradigm Clinical Research Centers, LLC
Paradigm Clinical Research Centers, LLC
Representatives
Rebecca Liebowitz VENABLE LLP
Technical classification
Nice Classes
Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business consulting and management in the field of clinical trialsclinical data and regulatory submission management on behalf of medicalbiopharmaceutically and biotechnology companies to assist them with clinical researchclinical trials and applications for drug approval; Business consulting and management in the field of clinical trialsmanagement and compilation of computerized databases in the field of clinical trials for business purposes; Business consulting and management in the field of clinical trialsproviding information management services; Clinical trial volunteer recruitment servicesrecruitment and placement of volunteers in the field of clinical trials; Recruitment advertisement servicesposting of clinical trial notices for the purpose of recruiting volunteer patients for participation in clinical trials
Class 42
Medical and scientific researchconducting clinical trials for others; Providing information in the field of clinical research via a website; Providing medical and scientific research information in the field of clinical trials; scientific and technical consulting services for others in the fields of clinical researchclinical study designclinical trial design; medical research; medical and scientific research in the fields of cardiologyvascular diseasesdermatologyendocrinologyneurologyinternal medicinepulmonologyinfectious diseasesmusculoskeletal ailmentsnutrition and weight lossobstetricsgynecologyotolaryngologypharmacologyrheumatologyvaccinespediatricsnephrologyophthalmologyoncologyhepatologymedical devicesgastroenterology; consulting services for others in the field of implementation project management of clinical trials
Publications
History of USPTO decisions and trademark events.
24 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/25/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/25/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/25/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/25/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/09/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
07/09/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/23/2024
PUBO
PUBLISHED FOR OPPOSITION
04/23/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/03/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/20/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
02/13/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/13/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
02/13/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/13/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/01/2023
GNRT
NON-FINAL ACTION E-MAILED
12/01/2023
CNRT
NON-FINAL ACTION WRITTEN
12/01/2023
DOCK
ASSIGNED TO EXAMINER
11/29/2023
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
08/26/2023
ALIE
ASSIGNED TO LIE
08/26/2023
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
04/13/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/21/2023
NWAP
NEW APPLICATION ENTERED
03/04/2023
Continuous trademark protection
Get notified about every new filing that threatens PARADIGM CLINICAL RESEARCH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.